Supplemental material
Emerging Microbes & Infections
Volume 13, 2024 - Issue 1
Open access
1,440
Views
0
CrossRef citations to date
0
Altmetric
Tuberculosis(TB)-what is new
A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis
Zhidong Hua Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Jingxian Xiaa Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Juan Wua Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Huimin Zhaoa Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Ping Jia Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Ling Gua Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Wenfei Gua Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Zhenyan Chena Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Jinchuan Xua Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Xuejiao Huanga Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Jian Mab ID Pharma, Ibaraki, JapanView further author information
, Anke Chenc State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Jixi Lic State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information
, Tsugumine Shub ID Pharma, Ibaraki, JapanView further author information
& Xiao-Yong Fana Shanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6654-3559View further author information
show allhttps://orcid.org/0000-0001-6654-3559View further author information
Article: 2300463
|
Received 14 Sep 2023, Accepted 24 Dec 2023, Published online: 04 Jan 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.